Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Silmitasertib sodium salt

🥰Excellent
Catalog No. T15024Cas No. 1309357-15-0
Alias CX-4945 sodium salt

Silmitasertib sodium salt (CX-4945 sodium salt) is a potent and orally bioavailable, highly selective inhibitor of CK2(IC50 of 1 nM, CK2α).

Silmitasertib sodium salt

Silmitasertib sodium salt

🥰Excellent
Purity: 99.62%
Catalog No. T15024Alias CX-4945 sodium saltCas No. 1309357-15-0
Silmitasertib sodium salt (CX-4945 sodium salt) is a potent and orally bioavailable, highly selective inhibitor of CK2(IC50 of 1 nM, CK2α).
Pack SizePriceAvailabilityQuantity
1 mg$30In Stock
5 mg$67In Stock
10 mg$97In Stock
25 mg$178In Stock
50 mg$289In Stock
100 mg$455In Stock
1 mL x 10 mM (in DMSO)$74In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Silmitasertib sodium salt"

Select Batch
Purity:99.62%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Silmitasertib sodium salt (CX-4945 sodium salt) is a potent and orally bioavailable, highly selective inhibitor of CK2(IC50 of 1 nM, CK2α).
Targets&IC50
CK2α:1 nM, CK2α':1 nM
In vitro
Silmitasertib induces cytotoxicity and apoptosis, and exerts anti-proliferative effects in hematological tumors by downregulating CK2 expression and suppressing activation of CK2-mediated PI3K/Akt/mTOR signaling pathways[3]. Silmitasertib (CX-4945) resultes in cell-cycle arrest and selectively induces apoptosis in cancer cells relative to normal cells, attenuates PI3K/Akt signalingand. The antiproliferative activity of Silmitasertib is correlated with expression levels of the CK2α catalytic subunit, attenuation of PI3K/Akt signaling[1]. Silmitasertib with PS-341 treatment prevents leukemic cells from engaging a functional UPR in order to buffer the PS-341-mediated proteotoxic stress in ER lumen, and decreases pro-survival ER chaperon BIP/Grp78 expression[2].
In vivo
Silmitasertib (CX-4945), administered at doses of 25 or 75 mg/kg orally, was well tolerated and demonstrated strong antitumor effects alongside significant decreases in the mechanistic biomarker phospho-p21 (T145) in murine xenograft models[1].
AliasCX-4945 sodium salt
Chemical Properties
Molecular Weight371.75
FormulaC19H11ClN3NaO2
Cas No.1309357-15-0
Smiles[Na+].[O-]C(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 12.5 mg/mL (33.62 mM), Sonication is recommended.
DMSO: 100 mg/mL (269.00 mM), Sonication is recommended.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM2.6900 mL13.4499 mL26.8998 mL134.4990 mL
5 mM0.5380 mL2.6900 mL5.3800 mL26.8998 mL
10 mM0.2690 mL1.3450 mL2.6900 mL13.4499 mL
20 mM0.1345 mL0.6725 mL1.3450 mL6.7249 mL
DMSO
1mg5mg10mg50mg
50 mM0.0538 mL0.2690 mL0.5380 mL2.6900 mL
100 mM0.0269 mL0.1345 mL0.2690 mL1.3450 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Silmitasertib sodium salt | purchase Silmitasertib sodium salt | Silmitasertib sodium salt cost | order Silmitasertib sodium salt | Silmitasertib sodium salt chemical structure | Silmitasertib sodium salt in vivo | Silmitasertib sodium salt in vitro | Silmitasertib sodium salt formula | Silmitasertib sodium salt molecular weight